In the current study, utilizing cardiac-specific genetic manipulation, we provided robust evidence suggesting that TRAF6 promotes the activation of TAK1, a MAPK kinase kinase (MAPKKK) that controls the downstream JNK1/2 and p38 MAPK cascades, during cardiac hypertrophy. The gene discussed is TRAF6; the disease is cardiac hypertrophy.